Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001553350-19-000862
Filing Date
2019-08-19
Accepted
2019-08-19 14:16:30
Documents
47
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDED QUARTERLY REPORT ephs_10qa.htm 10-Q/A 18408
2 CERTIFICATION ephs_ex31z1.htm EX-31 8273
3 CERTIFICATION ephs_ex31z2.htm EX-31.2 8275
4 CERTIFICATION ephs_ex32z1.htm EX-32 3588
5 CERTIFICATION ephs_ex32z2.htm EX-32.2 3610
  Complete submission text file 0001553350-19-000862.txt   1687324

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE stnn-20190630.xml EX-101.INS 269176
7 XBRL SCHEMA FILE stnn-20190630.xsd EX-101.SCH 24097
8 XBRL CALCULATION FILE stnn-20190630_cal.xml EX-101.CAL 42567
9 XBRL DEFINITION FILE stnn-20190630_def.xml EX-101.DEF 81011
10 XBRL LABEL FILE stnn-20190630_lab.xml EX-101.LAB 202320
11 XBRL PRESENTATION FILE stnn-20190630_pre.xml EX-101.PRE 152985
Mailing Address 5490 NOTRE DAME EST MONTREAL A8 H1N 2C4
Business Address 5490 NOTRE DAME EST MONTREAL A8 H1N 2C4 212-321-0091
EPHS HOLDINGS, INC. (Filer) CIK: 0001731911 (see all company filings)

EIN.: 824383947 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55906 | Film No.: 191035978
SIC: 2834 Pharmaceutical Preparations